Table 3 Serum CCL2 levels of the study subjects after adjusting the data for the covariates of gender and age
From: Serum levels of the chemokine CCL2 are elevated in malignant pleural mesothelioma patients
| Â | Unadjusted Data (ANOVA) | Adjusted Data (ANCOVA) | ||||||
|---|---|---|---|---|---|---|---|---|
Serum CCL2 (pg/ml) | Std Error | 95% CI | Estimated Serum CCL2 (pg/ml) | Std Error | 95% CI | |||
Lower Limit | Upper Limit | Lower Limit | Upper Limit | |||||
Unexposed (no apparent disease) | 275.2 | 22.9 | 230.2 | 320.3 | 305.5 | 24.2 | 256.0 | 351.1 |
Possibly Exposed (no apparent disease) | 307.5 | 7.8 | 292.2 | 322.8 | 305.4 | 7.7 | 290.4 | 320.8 |
Mesothelioma (stage 1 patients) | 289.9 | 41.5 | 208.4 | 371.4 | 275.7 | 41.1 | 195.0 | 356.5 |
Mesothelioma (stage 2 patients) | 281.0 | 64.4 | 154.7 | 407.3 | 261.0 | 63.6 | 136.0 | 386.0 |
Mesothelioma (stage 3 patients) | 486.0a,c,d | 38.4 | 410.5 | 561.5 | 471.4b,c,d | 38.1 | 396.4 | 546.3 |
Mesothelioma (stage 4 patients) | 493.5a,c,d | 33.0 | 428.7 | 558.3 | 492.5a,c,d,e | 32.7 | 428.3 | 556.7 |